122 — Columbus, Georgia

122 is a clinical research site located in Columbus, Georgia, United States 31904.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

122 has participated in 1 clinical trials.

Therapeutic areas: Abscess, Wound Infection, Surgical Site Infection.

Sponsors: Durata Therapeutics Inc., an affiliate of Allergan plc.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 122?

122 has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 122 conducted?

122 has 1 clinical trials on record. Their work covers Abscess, Wound Infection, Surgical Site Infection.

Is 122 accredited by Crixeo Health?

122 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 122?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.